Ketamine in Refractory Convulsive Status Epilepticus
Status:
Terminated
Trial end date:
2020-03-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of intravenous administration of ketamine in the treatment of
refractory convulsive status epilepticus in children compared to administration of midazolam
at high doses, thiopental and / or propofol.
Phase:
Phase 3
Details
Lead Sponsor:
Meyer Children's Hospital
Collaborators:
Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi Azienda Ospedaliera Universitaria Integrata Verona Bambino Gesù Hospital and Research Institute Catholic University of the Sacred Heart IRCCS Azienda Ospedaliero-Universitaria di Bologna IRCCS Burlo Garofolo Nuovo Regina Margherita Hospital Ospedali Riuniti Ancona University of Padova Vittore Buzzi Children's Hospital